Back to User profile » Dr Yingbin Luo

Papers published by Dr Yingbin Luo:

Retraction

Down-Regulation of SREBP via PI3K/AKT/mTOR Pathway Inhibits the Proliferation and Invasion of Non-Small-Cell Lung Cancer Cells [Retraction]

Zhang B, Wu J, Guo P, Wang Y, Fang Z, Tian J, Yu Y, Teng W, Luo Y, Li Y

OncoTargets and Therapy 2022, 15:1039-1040

Published Date: 23 September 2022

Original Research

RETRACTED ARTICLE: Down-Regulation of SREBP via PI3K/AKT/mTOR Pathway Inhibits the Proliferation and Invasion of Non-Small-Cell Lung Cancer Cells

Zhang B, Wu J, Guo P, Wang Y, Fang Z, Tian J, Yu Y, Teng W, Luo Y, Li Y

OncoTargets and Therapy 2020, 13:8951-8961

Published Date: 8 September 2020

Original Research

High expression of USP22 predicts poor prognosis and advanced clinicopathological features in solid tumors: a meta-analysis

Yang XH, Zang H, Luo Y, Wu J, Fang Z, Zhu W, Li Y

OncoTargets and Therapy 2018, 11:3035-3046

Published Date: 23 May 2018